• Clinical Evidence

Tight Glucose Control with Minimal Hypoglycemia

Setting: 874-bed regional academic medical center

Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results

  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.

Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.
Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results
  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.
Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.

References

Authors

Steve Cochran, MD; Kelli Dunn, MD; Will Miles, MD.

Source

Presented at American College of Chest Physicians Annual Meeting. Published in Chest, Volume 132, Issue 4, p564A.

Year

2007

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study evaluates use of EndoTool to achieve tight glucose control for critical care patients receiving intravenous insulin and constant nutrition.

Setting

874-bed regional academic medical center.

Results
  • Roughly half of blood glucose readings <40 mg/dL were associated with procedural errors, either a check more than 30 minutes late or no prior intravenous insulin infusion.
  • Aggregate incidence of hypoglycemia <40 mg/dL was 0.11% of blood glucose readings and 2.9% of patients; when excluding procedural errors, it was 0.05% of blood glucose readings and 1.6% of patients.
  • Mean blood glucose was 119.5 mg/dL (SD 35.9), and median blood glucose was 116 mg/dL.
  • Incidence of hypoglycemia, mean blood glucose, nosocomial infection and length of stay decreased over the study period, given use of EndoTool.
Conclusions

The clinical benefits of tight glucose control in critical care units can be safely achieved with use of EndoTool software.

References

Authors

Steve Cochran, MD; Kelli Dunn, MD; Will Miles, MD.

Source

Presented at American College of Chest Physicians Annual Meeting. Published in Chest, Volume 132, Issue 4, p564A.

Year

2007

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.